Navigation Links
Hologic Announces Third Quarter Fiscal 2011 Operating Results
Date:8/1/2011

o reconcile our non-GAAP adjusted EPS guidance to the most comparable GAAP measure. The Company's estimates of certain future non-GAAP adjustments, based upon current information, judgments and assumptions, are presented below for informational purposes.Three Months Ended Twelve Months EndedSeptember 24, 2011SharesSeptember 24, 2011Shares(In thousands)Certain Anticipated Non-GAAP Adjustments:  Cost of revenues - amortization of  intangible assets

$
44,800$
76,300  Amortization of intangible assets

15,40059,200  Non-cash interest expense relating to convertible

  notes

18,50072,900  Non-cash loss on convertible notes exchange

-29,891  Gain on sale of intellectual property, net

-(84,502)  Acquisition-related costs

-4,052  Fair value write-up of acquired inventory sold

-3,298  Contingent consideration

9,9008,500  Litigation settlement charges

-450  Income tax effect of reconciling items

(29,700)

(1)(90,500)

(1)Total Anticipated Non-GAAP Adjustments

$
58,900$
79,589Diluted Weighted Average Shares Outstanding265,500

(2)264,500

(2)Explanatory Notes:(1) To reflect an estimated annual effective tax rate of 33.5% for the fourth quarter and full year of fiscal 2011 on a non-GAAP basis.(2) To reflect estimated diluted weighted average shares outstanding of 265,500 and 264,500  for the fourth quarter and full year of

fiscal 2011, respectively.Use of Non-GAAP Financial Measures: The Company has presented the following non-GAAP financial measures in this press release: adjusted net income;
'/>"/>

SOURCE Hologic, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related medicine technology :

1. Three Year Analysis of Treatment Efficacy, Cosmesis, and Toxicity Support use of the Hologic Mammosite Radiation Therapy System
2. ALS Therapy Development Institute Partners with Clinical Centers to Establish Pathological Mechanisms of Lou Gehrigs Disease
3. Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials
4. Paclitaxel Poliglumex (OPAXIO(TM)) Added to Cisplatin and Radiation Produces 45% Pathologic Complete Remissions in Patients With Esophageal Cancer
5. Clinical and Histopathological Results Using Pollogens TriPollar(TM) Radio Frequency Technology Published in the June Issue of the Journal of Cosmetic and Laser Therapy
6. Hologic Receives CE Marking for the ThinPrep(R) Integrated Imager
7. OPAXIO Produces High Rates of Pathologic Complete Remission in Patients with Advanced Esophageal Cancer; Study Paves Way for Potential Registration Trial as Radiation Sensitizer
8. Hologic Expands Healthcare Investment in Asia
9. Hologic to Host Investor Reception at RSNA 2009
10. Hologic to Present at Citis 2009 Sixth Annual Small/Mid Cap Conference
11. Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... , Dec. 17, 2014  IGI Laboratories, Inc. (NYSE ... closing of its offering of $125 million aggregate principal ... "Notes").  The Notes were offered and sold only to ... Securities Act of 1933, as amended (the "Securities Act"). ... rate of 3.75% per year, payable semiannually in arrears ...
(Date:12/17/2014)... Dec. 17, 2014 PCCA received the ... ( http://bit.ly/1382OkS ) program seal for best practices ... program highlights medical practices, materials and goods that ... Children affected by autism often have ... exacerbated by ingredients found in food and medicine ...
(Date:12/15/2014)... Dec. 12, 2014 Research and Markets ... "Electrocardiogram (ECG) Devices - Global Trends, Estimates and ... http://photos.prnewswire.com/prnh/20130307/600769 Global Electrocardiogram ... by 2016. The North America ... share while Europe claims approximately ...
Breaking Medicine Technology:IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 2IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 4Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 2Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 3Electrocardiogram (ECG) Devices - Global Trends, Estimates and Forecasts, 2012-2018 2Electrocardiogram (ECG) Devices - Global Trends, Estimates and Forecasts, 2012-2018 3Electrocardiogram (ECG) Devices - Global Trends, Estimates and Forecasts, 2012-2018 4
... Epiphany Biosciences announced,today, the initiation of a Phase ... and management of acute infectious,mononucleosis. Currently, there are ... condition or any other disease caused by,the Epstein-Barr ... spectrum of anti-viral activity,including inhibition of viral replication ...
... 6 Some 5,000 COPD patients will be ... (Alpha-1) in,a study marking a major cooperative effort ... Respiratory Care (AARC)., The principal investigator is ... Pulmonary Medicine, National Jewish Medical and Research Center,in ...
Cached Medicine Technology:Epiphany Biosciences Reports Initiation of Phase 2 Study of Valomaciclovir for the Treatment of Acute Infectious Mononucleosis 2Alpha-1 Foundation, AARC Cooperate on Study to Test 5,000 COPD Patients for Alpha-1 2Alpha-1 Foundation, AARC Cooperate on Study to Test 5,000 COPD Patients for Alpha-1 3
(Date:12/19/2014)... December 19, 2014 Novellus Healthcare ... Care: Pharmacy & Clinics™, an independent journal that ... treating and caring for patients inside the pharmacy ... expands to provide optimal access to quality care, ... forum for the team treating and coordinating patient ...
(Date:12/19/2014)... Slone Partners , a ... healthcare information technology, and laboratory testing industries, has ... Operating Officer. The announcement comes after a year ... strengthened presence in Boston and several new additions ... breathes the client experience," said Adam Slone, Chief ...
(Date:12/19/2014)... (HealthDay News) -- Being in good shape seems to reduce ... looked at data from more than 57,000 Americans, including more ... between 1991 and 2009. Those in the poorest shape ... blood pressure at the start of the study, compared to ... fitness. Of the more than 8,000 people diagnosed with ...
(Date:12/19/2014)... Dec. 18, 2014 (HealthDay News) -- Traveling through the ... measles virus to three others within a four-hour time ... a new report shows. "The exposures in this ... rather than an international terminal, highlighting the fact that ... Jared Vega, an infectious disease specialist at the U.S. ...
(Date:12/17/2014)... Unidesk Corporation today announced that ... welcomed its inaugural class in August 2013, has ... support bring your own device (BYOD) and deliver ... The solution, comprised of Citrix XenDesktop ... and storage infrastructure and Unidesk virtual ...
Breaking Medicine News(10 mins):Health News:The Transformation of Retail Pharmacies into a Healthcare Delivery Center 2Health News:The Transformation of Retail Pharmacies into a Healthcare Delivery Center 3Health News:Slone Partners Promotes Leslie Loveless to Chief Operating Officer 2Health News:Being Fit Keeps Blood Pressure in Check 2Health News:Arriving Now at Gate 42: Measles 2Health News:Arriving Now at Gate 42: Measles 3Health News:Alabama College of Osteopathic Medicine Deploys Desktop Virtualization Solution from Citrix, Dell and Unidesk 2Health News:Alabama College of Osteopathic Medicine Deploys Desktop Virtualization Solution from Citrix, Dell and Unidesk 3
... May 6 Sunesis Pharmaceuticals, Inc. (Nasdaq: ... quarter ended March 31, 2009.Total revenue for the first ... loss of $8.4 million, including $1.9 million of restructuring ... and marketable securities totaled $4.3 million, with no debt ...
... leading university hospital has begun treatments using a new, ... improve outcomes while extending modern care to more patients. ... was the first patient in the country to be ... VAR ).Clinicians at Ajou University Hospital in ...
... /PRNewswire-Asia/ -- China Medicine Corporation,(OTC Bulletin Board: ... developer,and a leading distributor of prescription and ... nutritional and dietary supplements, and,medical devices and ... conduct,a conference call at 9:00 a.m. Eastern ...
... (Nasdaq: EFJI ) today announced its results for ... $11.5 million, or 34%, to $22.4 million for the three ... same period in 2008. This anticipated quarterly decline was attributable ... associated with the FCC re-banding effort. "While our state and ...
... NeoStem, Inc. (NYSE Amex: NBS ), which ... of adult stem cells for future medical need, has ... technology of Vincent C. Giampapa, M.D., F.A.C.S. relating ... February 2009.The newest adult stem cell collection center in ...
... NUCRYST Pharmaceuticals Corp., a developer and manufacturer of medical products ... for the first quarter of 2009. , For the quarter ... $1.1 million, or $0.06 cents per share, on revenues of ... million, or $0.12 cents per share, on revenues of $5.2 ...
Cached Medicine News:Health News:Sunesis Reports Financial Results for the First Quarter 2009 2Health News:Sunesis Reports Financial Results for the First Quarter 2009 3Health News:Sunesis Reports Financial Results for the First Quarter 2009 4Health News:Sunesis Reports Financial Results for the First Quarter 2009 5Health News:Sunesis Reports Financial Results for the First Quarter 2009 6Health News:Sunesis Reports Financial Results for the First Quarter 2009 7Health News:Sunesis Reports Financial Results for the First Quarter 2009 8Health News:Sunesis Reports Financial Results for the First Quarter 2009 9Health News:Ajou University Hospital Becomes First in Korea to Treat Using RapidArc(TM) Radiotherapy Technology from Varian Medical Systems 2Health News:Ajou University Hospital Becomes First in Korea to Treat Using RapidArc(TM) Radiotherapy Technology from Varian Medical Systems 3Health News:China Medicine Announces Conference Call to Discuss First Quarter 2009 Results 2Health News:EF Johnson Technologies, Inc. Announces First Quarter 2009 Financial Results 2Health News:EF Johnson Technologies, Inc. Announces First Quarter 2009 Financial Results 3Health News:EF Johnson Technologies, Inc. Announces First Quarter 2009 Financial Results 4Health News:EF Johnson Technologies, Inc. Announces First Quarter 2009 Financial Results 5Health News:EF Johnson Technologies, Inc. Announces First Quarter 2009 Financial Results 6Health News:NeoStem Files Patent Application for Cosmetic Stem Cell Face Lift Technology and Expands Stem Cell Collection Network into New Jersey 2Health News:NeoStem Files Patent Application for Cosmetic Stem Cell Face Lift Technology and Expands Stem Cell Collection Network into New Jersey 3Health News:NUCRYST announces 2009 first quarter financial results 2Health News:NUCRYST announces 2009 first quarter financial results 3Health News:NUCRYST announces 2009 first quarter financial results 4Health News:NUCRYST announces 2009 first quarter financial results 5Health News:NUCRYST announces 2009 first quarter financial results 6Health News:NUCRYST announces 2009 first quarter financial results 7
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: